Feed ONC
ON

BeOne Medicines AG

ONC · NASDAQ

$350.84 -0.37% (-$1.29)
1M -5.68%
Market Cap $37.5B
P/E Ratio 57.18x
Div. Yield -
ROE 14.24%

Bulios Fair Price

$349.5

0.4% downside

Current Price

$350.84

Undervalued Fair Value Overvalued

According to Bulios Fair Price, ONC is currently trading close to its fair value. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Moderate
6/9
Valuation
16 /100
Expensive
P/S 6.12x
P/E 57.18x
P/B 7.25x
Growth
83 /100
Growing
Book val. growth 0.17%
Rev. growth 55.69%
FCF growth N/A
Profitability
83 /100
Strong
Op. margin 15.06%
Gross margin 88.89%
FCF margin 20.28%
Quality
60 /100
Average
ROA 7.15%
ROIC 9.59%
Asset turnover 0.67x
Debt
100 /100
Low
Int. coverage 13.83x
Debt/Equity 0.22x
Net debt/EBITDA -3.41x
Stability
43 /100
Moderate
EPS volatility 336.73%
Beta 0.52x
Profitable years 1

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about ONC
Online

Sector

Healthcare

Industry

Biotechnology

CEO

John V. Oyler

Employees

12,000

Headquarters

Basel

Upcoming events

05 NOV

Earnings

Upcoming earnings report

45d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.